News and Trends 19 Nov 2018 Silk Biomaterial Could Regenerate the Brain After a Stroke …as Parkinson’s and Alzheimer’s, eye diseases like glaucoma and age-related macular degeneration, the repair of skin and tendons, and the treatment of incontinence and impotence caused by prostate surgery. Images… November 19, 2018 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 7 Feb 2020 EU Project Set up to Fight Alzheimer’s Disease with Lasers …some symptoms of Parkinson’s disease. Unlike these other techniques, the project aims to target specific brain networks, rather than individual brain regions or cells. “We are focused on the knowledge… February 7, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jan 2023 Ubiquigent and University of Glasgow to collaborate on drug discovery …has been proposed as a therapeutic strategy for Parkinson’s disease (PD). Although numerous USP30-targeting compounds are reported in scientific literature, only one has been approved to enter clinical evaluation so… January 24, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 20 Apr 2020 How Has Coronavirus Affected Europe’s Biotech Stocks? …its registrational study of its Parkinson’s disease candidate.” While many drugs are being delayed, it is also noteworthy that governments worldwide are willing to offer a vaccine to their citizens… April 20, 2020 - 12 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
News and Trends 2 Mar 2023 Ten new companies join BioInnovation Institute’s Venture Lab program …metastasis and determine the optimal chemotherapy; NorFalk, which produces sustainable surfactants; and Amplify Therapeutics, which is developing disease-modifying therapies for Gaucher disease and genetic subgroups of Parkinson’s disease. Since its… March 2, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jul 2019 The Top 10 Biotechs You’ll Find in Lyon …targeting neurons to enhance their effect. Founded in 2013, Theranexus has three drug candidates being tested in clinical trials to treat narcolepsy, sleepiness in Parkinson’s disease, Alzheimer’s, and neuropathic pain…. July 10, 2019 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 21 Mar 2025 Depression drug trials are failing—and placebos are to blame …treatment-resistant depression. American healthcare company Abbott has begun a pivotal clinical trial, having previously been successful in helping manage Parkinson’s disease and essential tremor symptoms. Meanwhile, Neurocrine Biosciences has launched… March 21, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Mar 2023 Antiverse identifies therapeutic antibodies targeting GPCRs …Scale, as well as existing investors, Tensor Ventures, Deep Science Ventures, Ed Parkinson and Development Bank of Wales (DBW). Murat Tunaboylu, co-founder and CEO of Antiverse, said: “This is the… March 2, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jun 2020 Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS …and the neurodegenerative condition Parkinson’s disease. “Pridopidine’s mechanism as a sigma-1 receptor agonist is relevant to multiple neurodegenerative diseases as it rescues cellular processes that are commonly impaired in several… June 5, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2020 Boost For Inflammatory Disease Biotech NodThera With €49M Series B …fibrosis…to inflammatory bowel disease, neurodegenerative diseases such as Alzheimer’s and Parkinson’s, and certain cancers.” Research suggests that selectively blocking the action of the NLRP3 inflammasome can help treat the overactivation… June 6, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 15 May 2023 Alzheimer’s drugs could result from immune brain cell discovery …for proper brain development and function. Cognitive decline is a common feature of neurodegenerative and psychiatric conditions like Alzheimer’s and Parkinson’s disease, schizophrenia and depression,” said Vassilis Stratoulias, senior researcher… May 15, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Feb 2022 Top 10 Biotech Companies in Stevenage, UK’s Hidden Life Sciences Gem …develop drugs for Parkinson’s and other related disorders. Autolus Therapeutics Founded: 2014 A spin-out of University College London, Autolus Therapeutics develops CAR-T cell therapies for cancer. The approach consists of… February 16, 2022 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email